Specialty Pharmacy Solutions for Retina Specialists: Improving Medication Access and Workflow
For retina specialists, consistency is everything. When treatment schedules are tightly managed and patient volumes are high, having reliable access to medication is critical to ensure continuity of care.
That’s why many providers are turning to specialty pharmacy programs that help coordinate medication access, delivery and support. This is especially important when you consider the burden placed on providers. Physicians and their staff spend the equivalent of two or more days per week on prior-authorization tasks1, which are required for many specialties.
A retina specialty pharmacy approach can play a key role in making all that possible.
The Reality of High-Volume Ophthalmology Care
Retina specialists operate in one of the most demanding clinical environments. Managing conditions like Wet Age-Related Macular Degeneration (Wet AMD) and diabetic macular edema requires ongoing injections, often delivered on a strict schedule. For example, therapies used to treat wet AMD and diabetic macular edema are typically administered every 4–8 weeks2 initially, and then may require ongoing, repeated injections to maintain disease control.
This level of ongoing care creates constant pressure on practices to maintain:
- Consistent medication supply
- Efficient workflows
- Timely patient scheduling
When any part of that system breaks down, especially medication availability, it can disrupt the entire care process.
Challenges with Medication Access and Workflow
Many practices still rely on traditional sourcing methods, which can create inconsistencies in their day-to-day operations. Time spent coordinating medication access, navigating prior authorizations or managing inventory can quickly add up.
This can also impact the patient experience. Delays or inconsistencies in ophthalmology medication delivery to the office can lead to rescheduled appointments or interruptions in care.
How a Coordinated Specialty Pharmacy Model Helps
A well-designed ophthalmology specialty pharmacy program helps make it easier and more reliable for these pharmacies to get medications. Instead of juggling many separate steps, providers can follow a clear, coordinated process that simplifies ordering, delivery and communication.
This is where specialty pharmacy solutions for retina specialists become especially valuable. By aligning pharmacy services with practice needs, these models help ensure that medications are available when and where they are needed.
What This Means for Your Practice
With the right support in place, providers can experience meaningful improvements to their workflows and patient care.
Reliable ophthalmology medication delivery keeps injection schedules on track and reduces last-minute disruptions. Simplifying the approval and insurance process also saves staff time, allowing teams to focus more on patient care. Over time, this consistency builds confidence, not only within the practice but also among patients who rely on timely treatment to preserve their vision.
A More Connected Care Experience
Modern specialty pharmacy ophthalmology services do more than deliver medication. They create a more connected experience across providers, pharmacy teams and health plans.
Through a coordinated ophthalmology drug-supply model, practices benefit from clearer communication, more predictable processes and stronger overall support. This helps ensure medications are available when needed, that day-to-day operations run more smoothly, and that patients stay on track with their treatment.
A More Reliable Approach to Supporting Retina Specialists
As ophthalmology continues to evolve, providers need solutions that support both clinical excellence and operational efficiency. A coordinated ophthalmology specialty pharmacy model offers a reliable way to streamline medication access while maintaining high-quality patient care.
Discover how California Specialty Pharmacy supports retina specialists with reliable medication access and coordinated delivery with our new program, RetinaCare Complete, here: https://csprx.com/ophthalmology.
References:
- American Academy of Ophthalmology, Prior Authorization, 2025
https://www.aao.org/advocacy/prior-authorization - iovs, High-dose, High-frequency intravitreal aflibercept for Wet AMD, April 2026
https://iovs.arvojournals.org/article.aspx?articleid=2768439
Legal Disclaimer:
The content provided in this article is based on industry experience and is for informational purposes only. It is not intended to serve as legal, regulatory, or reimbursement advice. While we make every effort to provide accurate and up-to-date information, the details shared here should not be considered a substitute for professional consultation or advice.
By accessing this content, you agree to hold harmless the author, publisher, and any associated parties from any claims, liabilities, or damages arising from the use or interpretation of this content.
©2026 Acelpa Health, LLC. All rights reserved.
